Results 1 to 10 of about 3,398 (179)

The Induction of Oxidative/Nitrosative Stress, Inflammation, and Apoptosis by a Ferric Carboxymaltose Copy Compared to Iron Sucrose in a Non-Clinical Model [PDF]

Journal of Clinical and Diagnostic Research, 2015
Introduction: Ferric carboxymaltose is a next-generation polynuclear iron(III)-hydroxide carbohydrate complex for intravenous iron therapy belonging to the class of so-called non-biological complex drugs.
Jorge E. Toblli, Gabriel Cao, Margarita Angerosa   +2 more
doaj   +3 more sources

Impact of Intravenous Ferric Carboxymaltose on Quality of Life in Patients with Iron Deficiency Anemia: A Prospective Observational Study [PDF]

International Journal of General Medicine
Rıfat Bozkuş, Emin Gemcioğlu, Şeyma Sarışen Department of Internal Medicine, Ankara Etlik City Hospital, Ankara, TurkeyCorrespondence: Rıfat Bozkuş, Department of ...
Bozkuş R, Gemcioğlu E, Sarışen Ş
doaj   +2 more sources

The experiences of ferric carboxymaltose desensitization and provocation [PDF]

World Allergy Organization Journal
Background: To present the characteristics of drug hypersensitivity reactions (DHR) among iron preparations and to describe the outcomes of rapid drug desensitization (RDD) and drug provocation tests (DPT) of ferric carboxymaltose (FCM).
Fatma Dindar Çelik, MD, Kurtuluş Aksu, MD, Özgür Akkale, MD, Hatice Çelik Tuğlu, MD, Melis Yağdıran, MD, Onur Telli, MD, Gürgün Tuğçe Vural Solak, MD, Enes Çelik, MD   +7 more
doaj   +2 more sources

Ferric Carboxymaltose [PDF]

Hospital Pharmacy, 2014
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Cada, Dennis J, Levien, Terri L, Baker, Danial E   +2 more
openaire   +4 more sources

Effect of parenteral iron treatment on platelet counts in women who do not have concomitant diseases

Iraqi Journal of Hematology, 2022
BACKGROUND: Iron replacement may change platelet counts. Parenteral iron treatment has different effects on platelets count in some diseases. the aim of this study was to inspect the effect of parenteral ferric carboxymaltose treatment on platelet counts
Recep Alanli, Murat Bulent Kucukay
doaj   +1 more source

Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients

Pharmaceutics, 2022
Anemia is a major complication of end-stage kidney disease (ESKD). Erythropoiesis-stimulating agents and intravenous (IV) iron are the current backbone of anemia treatment in ESKD.
Guy Rostoker, Fanny Lepeytre, Myriam Merzoug, Mireille Griuncelli, Christelle Loridon, Ghada Boulahia, Yves Cohen   +6 more
doaj   +1 more source

Comparative study of efficacy of intravenous iron sucrose versus ferric carboxymaltose in the treatment of iron deficiency anaemia

Haematology Journal of Bangladesh, 2020
Background: Iron deficiency anaemia (IDA) is a common haematological complication with potentially serious clinical consequences that may require intravenous iron therapy.
Huque Mahfuz, Mohammad Elias Hossain, Mohammed Mosleh Uddin, Mostafil Karim   +3 more
doaj   +1 more source

Switching patients with non-dialysis chronic kidney disease from oral iron to intravenous ferric carboxymaltose: effects on erythropoiesis-stimulating agent requirements, costs, hemoglobin and iron status. [PDF]

PLoS ONE, 2015
Patients with non-dialysis-dependent chronic kidney disease (ND-CKD) often receive an erythropoiesis-stimulating agent (ESA) and oral iron treatment. This study evaluated whether a switch from oral iron to intravenous ferric carboxymaltose can reduce ESA
Jorge Eduardo Toblli, Federico Di Gennaro   +1 more
doaj   +1 more source

Comparison of the use of intravenous iron sucrose with intravenous ferric Carboxymaltose for treatment of iron deficiency anaemia in pregnant patients

Journal of University Medical & Dental College, 2022
BACKGROUND & OBJECTIVE: Iron deficiency results in major disabilities and death all over the world, about two billion people are suffering from anaemia at the moment. To compare intravenous iron sucrose with intravenous ferric carboxymaltose in terms of
Khar un-Nisa, Rukhsana Shaheen Afzal, Faiza Safdar, Noreen Majeed, Shabana Kalsoom, Irum Mushtaq   +5 more
doaj   +1 more source

Ferric Carboxymaltose (FCM)–Associated Hypophosphatemia (HPP): A Systematic Review [PDF]

American Journal of Hematology
Joseph Magagnoli, William J Hrushesky, Kenneth R Carson   +2 more
exaly   +2 more sources